NCT04008082 2022-03-08
A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma
Eisai Inc.
Completed
Clinical Trials
3 trialsNCT02454478 2019-03-19
Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)
Eisai Inc.
Phase 1 Completed
NCT00946153 2019-02-01
Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)
Eisai Inc.
Phase 1/2 Completed